FORMULATIONS COMPRISING IMIQUIMOD OR OTHER IMMUNE RESPONSE MODIFIERS FOR TREATING MUCOSAL CONDITIONS

摘要

Immune response modifier (IRM) compounds - imidazoquinoline amines, imidazopyridine amines, 6,7-fused cy-cloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, thiazolo- and oxazolo- quinolinamines and pyridinamines, imidazonaphthyridine and tetrahydroimidazonaphthyridine amines - are useful for the treatment of conditions at and below the mu-cosal surfaces by administering a therapeutically effective amount of suc h compounds to the mucosal surface. Novel pharmaceutical formulations are provided. In one embodiment, the pharmaceutical formulation s are advantageous for treatment of cervical condi-tions such as cervical dysplasias including cervical intraepithelial neoplasias.